Kewaunee Scientific (NASDAQ:KEQU) VP Elizabeth Phillips Sells 6,880 Shares

Kewaunee Scientific Corporation (NASDAQ:KEQU) VP Elizabeth Phillips sold 6,880 shares of the company’s stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $43.20, for a total transaction of $297,216.00. Following the completion of the transaction, the vice president owned 8,248 shares in the company, valued at approximately $356,313.60. This represents a 45.48% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Kewaunee Scientific Stock Down 2.0%

KEQU opened at $43.31 on Friday. The company has a quick ratio of 1.63, a current ratio of 2.32 and a debt-to-equity ratio of 0.88. The firm has a 50 day moving average price of $51.96 and a 200-day moving average price of $45.29. Kewaunee Scientific Corporation has a twelve month low of $30.33 and a twelve month high of $71.33. The stock has a market capitalization of $124.13 million, a price-to-earnings ratio of 10.49 and a beta of 0.68.

Kewaunee Scientific (NASDAQ:KEQU) last released its quarterly earnings data on Wednesday, September 10th. The technology company reported $1.10 earnings per share for the quarter. Kewaunee Scientific had a net margin of 4.68% and a return on equity of 25.65%. The firm had revenue of $71.10 million during the quarter.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen raised shares of Kewaunee Scientific from a “hold” rating to a “buy” rating in a report on Saturday, July 5th.

Institutional Trading of Kewaunee Scientific

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Punch & Associates Investment Management Inc. bought a new position in shares of Kewaunee Scientific in the first quarter worth approximately $788,000. American Century Companies Inc. boosted its position in shares of Kewaunee Scientific by 43.4% in the first quarter. American Century Companies Inc. now owns 49,182 shares of the technology company’s stock worth $1,937,000 after purchasing an additional 14,889 shares during the period. Goldman Sachs Group Inc. boosted its position in shares of Kewaunee Scientific by 125.7% in the first quarter. Goldman Sachs Group Inc. now owns 19,397 shares of the technology company’s stock worth $764,000 after purchasing an additional 10,803 shares during the period. OMERS ADMINISTRATION Corp bought a new position in shares of Kewaunee Scientific in the first quarter worth approximately $284,000. Finally, Mink Brook Asset Management LLC bought a new position in shares of Kewaunee Scientific in the second quarter worth approximately $370,000. 32.69% of the stock is owned by hedge funds and other institutional investors.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.